The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA's premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop.
1 Front Matter; 2 1 Introduction; 3 2 Legislative History of the Medical Device Amendments of 1976; 4 3 Premarket Notification; 5 4 The Medical Device Industry Innovation Ecosystem; 6 5 The Global Framework for Regulation of Medical Devices; 7 6 Public Comments; 8 Appendix A: Workshop Agenda; 9 Appendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers; 10 Appendix C: Premarket Notification: A Key Element of US Medical Device Regulation--Larry Kessler and Philip J. Phillips; 11 Appendix D: Impact of the Regulatory Framework on Medical Device Development and Innovation--David W. Feigal, Jr
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process
and Medicine National Academies of Sciences, Engineering, Transportation Research Board, Health and Medicine Division, Board on Population Health and Public Health Practice, Alina Baciu, Theresa Wizemann
and Medicine National Academies of Sciences, Engineering, Institute of Medicine, Board on Population Health and Public Health Practice, Roundtable on Population Health Improvement, Darla Thompson, Theresa Wizemann
Institute of Medicine, Board on Population Health and Public Health Practice, Roundtable on Population Health Improvement, Darla Thompson, Theresa Wizemann
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Roundtable on Population Health Improvement, Theresa Wizemann